TD Asset Management
EXAS

TD Asset Management’s Exact Sciences EXAS Stock Holding History

TD Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-132,304
Closed -$7.24M – 1256
2025
Q3 		$7.24M Sell
132,304
-36,800
-22% -$1.84M 0.01% 724
2025
Q2 		$8.99M Sell
169,104
-184,667
-52% -$9.38M 0.01% 659
2025
Q1 		$15.3M Sell
353,771
-142,273
-29% -$7.2M 0.01% 549
2024
Q4 		$27.9M Buy
496,044
+18,288
+4% +$1.14M 0.02% 429
2024
Q3 		$31.5M Buy
477,756
+114,782
+32% +$6.48M 0.03% 392
2024
Q2 		$15.3M Sell
362,974
-16,738
-4% -$921K 0.01% 548
2024
Q1 		$26.2M Sell
379,712
-5,503
-1% -$348K 0.02% 422
2023
Q4 		$28.5M Sell
385,215
-34,655
-8% -$2.27M 0.03% 390
2023
Q3 		$28.6M Buy
419,870
+69,071
+20% +$5.86M 0.03% 364
2023
Q2 		$32.9M Buy
350,799
+26,432
+8% +$2.06M 0.04% 342
2023
Q1 		$22M Buy
324,367
+9,833
+3% +$632K 0.03% 420
2022
Q4 		$15.6M Sell
314,534
-29,922
-9% -$1.22M 0.02% 490
2022
Q3 		$11.4M Sell
344,456
-13,870
-4% -$572K 0.01% 547
2022
Q2 		$14.1M Sell
358,326
-11,254
-3% -$602K 0.02% 517
2022
Q1 		$25.8M Sell
369,580
-13,434
-4% -$982K 0.02% 421
2021
Q4 		$29.8M Buy
383,014
+103,367
+37% +$9.12M 0.03% 412
2021
Q3 		$26.7M Sell
279,647
-1,411
-0.5% -$149K 0.03% 409
2021
Q2 		$30.3M Buy
281,058
+21,597
+8% +$2.58M 0.03% 389
2021
Q1 		$34.2M Buy
259,461
+15,681
+6% +$2.15M 0.04% 354
2020
Q4 		$32.3M Sell
243,780
-100,870
-29% -$12.2M 0.04% 329
2020
Q3 		$35.1M Buy
344,650
+24,002
+7% +$2.07M 0.05% 276
2020
Q2 		$27.9M Buy
320,648
+12,373
+4% +$989K 0.04% 297
2020
Q1 		$17.9M Buy
308,275
+69,335
+29% +$5.63M 0.03% 342
2019
Q4 		$22.1M Buy
238,940
+101,644
+74% +$8.94M 0.03% 366
2019
Q3 		$12.4M Buy
137,296
+12,106
+10% +$1.38M 0.02% 469
2019
Q2 		$14.8M Buy
125,190
+2,990
+2% +$301K 0.02% 427
2019
Q1 		$10.6M Sell
122,200
-9,500
-7% -$809K 0.02% 506
2018
Q4 		$8.31M Sell
131,700
-10,600
-7% -$727K 0.01% 527
2018
Q3 		$11.2M Buy
142,300
+84,700
+147% +$5.52M 0.02% 517
2018
Q2 		$3.44M Buy
+57,600
New +$3.1M 0.01% 804
2014
Q3 		– Sell
-13,100
Closed -$223K – 1322
2014
Q2 		$223K Buy
+13,100
New +$180K ﹤0.01% 1208

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TD Asset Management's EXAS Position: Q4 2025 in Review

TD Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 132,304 shares — an estimated $7.24M sold.

TD Asset Management first reported a position in EXAS in Q2 2014 and held it in 31 quarters. The position peaked at $35.1M in Q3 2020. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • TD Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • TD Asset Management sold 132,304 Exact Sciences shares in Q4 2025, an estimated $7.24M.
  • TD Asset Management first reported a position in Exact Sciences in Q2 2014 and held it in 31 quarters.
  • TD Asset Management's Exact Sciences position peaked at $35.1M in Q3 2020.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on TD Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.